Skip navigation



Networking Comes of Age as Cambridge Network Turns 21

The Cambridge Network celebrates its 21st birthday this year, proving its success as one of the world’s most effective and best-established business networking organisations. More »
12 June 2018

Avacta Group plc announces the appointment of Dr Eliot Forster as Non-Executive Chairman

Highly experienced pharma/biotech professional to lead Avacta’s Board More »
11 June 2018

Dr Darrin M Disley Awarded OBE

Scientist, entrepreneur and enterprise champion, Dr Darrin M Disley has been appointed an Officer of the Order of the British Empire (OBE) in the Queen’s Birthday honours list 2018. The OBE has been awarded to Darrin for his services to business, enterprise and health, recognising his achievement in the advancement of the UK life science industry, and support of student entrepreneurs and their businesses. More »
11 June 2018

IONTAS Signs Collaboration Agreement with LG Chem Ltd to Identify Therapeutic Oncology Leads

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic antibodies targeting undisclosed targets for use in the treatment of cancers. Under the agreement IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by LG Chem, Ltd. and to further prove the biological activity of the antibodies. More »
06 June 2018

Thermo Fisher Scientific brought Science World to Spain for the first time

Science World, the Fisher Scientific Laboratory Experience, made its successful launch in Spain at the IFEMA North Convention Centre in Madrid on 24 May 2018 More »
06 June 2018

Microbiotica Enters into Microbiome Collaboration with Genentech

Microbiotica, a leading player in microbiome-based therapeutics spun out of the Wellcome Sanger Institute, today announced that it has entered into a multi-year strategic collaboration with Genentech, a member of the Roche Group, to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease (IBD). More »
06 June 2018

Silence Therapeutics Announces Leadership Change

Silence Therapeutics plc, AIM:SLN (“Silence” or “the Company”) a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases, announces today that Ali Mortazavi is stepping down as Chief Executive Officer and as a Director of the Company with immediate effect after having served the Company for six years. Dr Annalisa Jenkins, Chair of Silence Therapeutics, is today assuming the role of Executive Chair in an interim capacity to ensure a smooth transition until a new Chief Executive Officer is appointed. More »
05 June 2018

Cell Culture Medium for Clinical Research - AMSBIO

AMSBIO announces the launch of StemFit® Basic03 clinical grade stem cell culture for regenerative medicine. More »
05 June 2018

Life Science Trade Visit Bound for Boston, USA on New Direct Flights from London Stansted

More than 20 businesses from across the Life Science sector are set to bang the East of England drum with a trade visit to celebrate the launch of Primera Air’s direct flight between London Stansted and Boston, USA. More »
05 June 2018

Cambridge Network Reports Demand for In-house Courses as Businesses Choose to Upskill Staff

With recruitment becoming more challenging for local businesses, many companies are choosing to upskill their staff. And there has been a surge in requests for in-house courses from Cambridge Network's Learning Collaboration, reports the team. More »
05 June 2018

<< Previous   Page 2 of 41   Next >>